This report contains market size and forecasts of Peptide Antibiotics in global, including the following market information:
Global Peptide Antibiotics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Peptide Antibiotics Market Sales, 2016-2021, 2022-2027, (MT)
Global top five Peptide Antibiotics companies in 2020 (%)
The global Peptide Antibiotics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide Antibiotics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Antibiotics Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Peptide Antibiotics Market Segment Percentages, By Type, 2020 (%)
Ribosomal Synthesized Peptide Antibiotics
Non-Ribosomally Synthesized Peptide Antibiotics
Global Peptide Antibiotics Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Peptide Antibiotics Market Segment Percentages, By Application, 2020 (%)
Pharma & Healthcare
Food Industry
Commodities
Other
Global Peptide Antibiotics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Peptide Antibiotics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Antibiotics revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Peptide Antibiotics revenues share in global market, 2020 (%)
Key companies Peptide Antibiotics sales in global market, 2016-2021 (Estimated), (MT)
Key companies Peptide Antibiotics sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
GlaxoSmithKline
Eli Lilly
Theravance
Vicuron Pharmaceuticals
Savara Pharmaceuticals
AMP Therapeutics
Hospira
Kasten
Madam Therapeutics
Phosphagenics
Pacgen Life Science Corporation
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Peptide Antibiotics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide Antibiotics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide Antibiotics Overall Market Size
2.1 Global Peptide Antibiotics Market Size: 2021 VS 2027
2.2 Global Peptide Antibiotics Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Peptide Antibiotics Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Peptide Antibiotics Players in Global Market
3.2 Top Global Peptide Antibiotics Companies Ranked by Revenue
3.3 Global Peptide Antibiotics Revenue by Companies
3.4 Global Peptide Antibiotics Sales by Companies
3.5 Global Peptide Antibiotics Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Peptide Antibiotics Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Peptide Antibiotics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptide Antibiotics Players in Global Market
3.8.1 List of Global Tier 1 Peptide Antibiotics Companies
3.8.2 List of Global Tier 2 and Tier 3 Peptide Antibiotics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Peptide Antibiotics Market Size Markets, 2021 & 2027
4.1.2 Ribosomal Synthesized Peptide Antibiotics
4.1.3 Non-Ribosomally Synthesized Peptide Antibiotics
4.2 By Type - Global Peptide Antibiotics Revenue & Forecasts
4.2.1 By Type - Global Peptide Antibiotics Revenue, 2016-2021
4.2.2 By Type - Global Peptide Antibiotics Revenue, 2022-2027
4.2.3 By Type - Global Peptide Antibiotics Revenue Market Share, 2016-2027
4.3 By Type - Global Peptide Antibiotics Sales & Forecasts
4.3.1 By Type - Global Peptide Antibiotics Sales, 2016-2021
4.3.2 By Type - Global Peptide Antibiotics Sales, 2022-2027
4.3.3 By Type - Global Peptide Antibiotics Sales Market Share, 2016-2027
4.4 By Type - Global Peptide Antibiotics Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptide Antibiotics Market Size, 2021 & 2027
5.1.2 Pharma & Healthcare
5.1.3 Food Industry
5.1.4 Commodities
5.1.5 Other
5.2 By Application - Global Peptide Antibiotics Revenue & Forecasts
5.2.1 By Application - Global Peptide Antibiotics Revenue, 2016-2021
5.2.2 By Application - Global Peptide Antibiotics Revenue, 2022-2027
5.2.3 By Application - Global Peptide Antibiotics Revenue Market Share, 2016-2027
5.3 By Application - Global Peptide Antibiotics Sales & Forecasts
5.3.1 By Application - Global Peptide Antibiotics Sales, 2016-2021
5.3.2 By Application - Global Peptide Antibiotics Sales, 2022-2027
5.3.3 By Application - Global Peptide Antibiotics Sales Market Share, 2016-2027
5.4 By Application - Global Peptide Antibiotics Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Peptide Antibiotics Market Size, 2021 & 2027
6.2 By Region - Global Peptide Antibiotics Revenue & Forecasts
6.2.1 By Region - Global Peptide Antibiotics Revenue, 2016-2021
6.2.2 By Region - Global Peptide Antibiotics Revenue, 2022-2027
6.2.3 By Region - Global Peptide Antibiotics Revenue Market Share, 2016-2027
6.3 By Region - Global Peptide Antibiotics Sales & Forecasts
6.3.1 By Region - Global Peptide Antibiotics Sales, 2016-2021
6.3.2 By Region - Global Peptide Antibiotics Sales, 2022-2027
6.3.3 By Region - Global Peptide Antibiotics Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Peptide Antibiotics Revenue, 2016-2027
6.4.2 By Country - North America Peptide Antibiotics Sales, 2016-2027
6.4.3 US Peptide Antibiotics Market Size, 2016-2027
6.4.4 Canada Peptide Antibiotics Market Size, 2016-2027
6.4.5 Mexico Peptide Antibiotics Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Peptide Antibiotics Revenue, 2016-2027
6.5.2 By Country - Europe Peptide Antibiotics Sales, 2016-2027
6.5.3 Germany Peptide Antibiotics Market Size, 2016-2027
6.5.4 France Peptide Antibiotics Market Size, 2016-2027
6.5.5 U.K. Peptide Antibiotics Market Size, 2016-2027
6.5.6 Italy Peptide Antibiotics Market Size, 2016-2027
6.5.7 Russia Peptide Antibiotics Market Size, 2016-2027
6.5.8 Nordic Countries Peptide Antibiotics Market Size, 2016-2027
6.5.9 Benelux Peptide Antibiotics Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Peptide Antibiotics Revenue, 2016-2027
6.6.2 By Region - Asia Peptide Antibiotics Sales, 2016-2027
6.6.3 China Peptide Antibiotics Market Size, 2016-2027
6.6.4 Japan Peptide Antibiotics Market Size, 2016-2027
6.6.5 South Korea Peptide Antibiotics Market Size, 2016-2027
6.6.6 Southeast Asia Peptide Antibiotics Market Size, 2016-2027
6.6.7 India Peptide Antibiotics Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Peptide Antibiotics Revenue, 2016-2027
6.7.2 By Country - South America Peptide Antibiotics Sales, 2016-2027
6.7.3 Brazil Peptide Antibiotics Market Size, 2016-2027
6.7.4 Argentina Peptide Antibiotics Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Peptide Antibiotics Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Peptide Antibiotics Sales, 2016-2027
6.8.3 Turkey Peptide Antibiotics Market Size, 2016-2027
6.8.4 Israel Peptide Antibiotics Market Size, 2016-2027
6.8.5 Saudi Arabia Peptide Antibiotics Market Size, 2016-2027
6.8.6 UAE Peptide Antibiotics Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Peptide Antibiotics Major Product Offerings
7.1.4 Pfizer Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Peptide Antibiotics Major Product Offerings
7.2.4 Novartis Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Peptide Antibiotics Major Product Offerings
7.3.4 GlaxoSmithKline Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.3.5 GlaxoSmithKline Key News
7.4 Eli Lilly
7.4.1 Eli Lilly Corporate Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Peptide Antibiotics Major Product Offerings
7.4.4 Eli Lilly Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.4.5 Eli Lilly Key News
7.5 Theravance
7.5.1 Theravance Corporate Summary
7.5.2 Theravance Business Overview
7.5.3 Theravance Peptide Antibiotics Major Product Offerings
7.5.4 Theravance Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.5.5 Theravance Key News
7.6 Vicuron Pharmaceuticals
7.6.1 Vicuron Pharmaceuticals Corporate Summary
7.6.2 Vicuron Pharmaceuticals Business Overview
7.6.3 Vicuron Pharmaceuticals Peptide Antibiotics Major Product Offerings
7.6.4 Vicuron Pharmaceuticals Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.6.5 Vicuron Pharmaceuticals Key News
7.7 Savara Pharmaceuticals
7.7.1 Savara Pharmaceuticals Corporate Summary
7.7.2 Savara Pharmaceuticals Business Overview
7.7.3 Savara Pharmaceuticals Peptide Antibiotics Major Product Offerings
7.4.4 Savara Pharmaceuticals Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.7.5 Savara Pharmaceuticals Key News
7.8 AMP Therapeutics
7.8.1 AMP Therapeutics Corporate Summary
7.8.2 AMP Therapeutics Business Overview
7.8.3 AMP Therapeutics Peptide Antibiotics Major Product Offerings
7.8.4 AMP Therapeutics Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.8.5 AMP Therapeutics Key News
7.9 Hospira
7.9.1 Hospira Corporate Summary
7.9.2 Hospira Business Overview
7.9.3 Hospira Peptide Antibiotics Major Product Offerings
7.9.4 Hospira Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.9.5 Hospira Key News
7.10 Kasten
7.10.1 Kasten Corporate Summary
7.10.2 Kasten Business Overview
7.10.3 Kasten Peptide Antibiotics Major Product Offerings
7.10.4 Kasten Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.10.5 Kasten Key News
7.11 Madam Therapeutics
7.11.1 Madam Therapeutics Corporate Summary
7.11.2 Madam Therapeutics Peptide Antibiotics Business Overview
7.11.3 Madam Therapeutics Peptide Antibiotics Major Product Offerings
7.11.4 Madam Therapeutics Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.11.5 Madam Therapeutics Key News
7.12 Phosphagenics
7.12.1 Phosphagenics Corporate Summary
7.12.2 Phosphagenics Peptide Antibiotics Business Overview
7.12.3 Phosphagenics Peptide Antibiotics Major Product Offerings
7.12.4 Phosphagenics Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.12.5 Phosphagenics Key News
7.13 Pacgen Life Science Corporation
7.13.1 Pacgen Life Science Corporation Corporate Summary
7.13.2 Pacgen Life Science Corporation Peptide Antibiotics Business Overview
7.13.3 Pacgen Life Science Corporation Peptide Antibiotics Major Product Offerings
7.13.4 Pacgen Life Science Corporation Peptide Antibiotics Sales and Revenue in Global (2016-2021)
7.13.5 Pacgen Life Science Corporation Key News
8 Global Peptide Antibiotics Production Capacity, Analysis
8.1 Global Peptide Antibiotics Production Capacity, 2016-2027
8.2 Peptide Antibiotics Production Capacity of Key Manufacturers in Global Market
8.3 Global Peptide Antibiotics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Peptide Antibiotics Supply Chain Analysis
10.1 Peptide Antibiotics Industry Value Chain
10.2 Peptide Antibiotics Upstream Market
10.3 Peptide Antibiotics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peptide Antibiotics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Peptide Antibiotics in Global Market
Table 2. Top Peptide Antibiotics Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Peptide Antibiotics Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Peptide Antibiotics Revenue Share by Companies, 2016-2021
Table 5. Global Peptide Antibiotics Sales by Companies, (MT), 2016-2021
Table 6. Global Peptide Antibiotics Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Peptide Antibiotics Price (2016-2021) & (USD/Kg)
Table 8. Global Manufacturers Peptide Antibiotics Product Type
Table 9. List of Global Tier 1 Peptide Antibiotics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide Antibiotics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Pfizer
Novartis
GlaxoSmithKline
Eli Lilly
Theravance
Vicuron Pharmaceuticals
Savara Pharmaceuticals
AMP Therapeutics
Hospira
Kasten
Madam Therapeutics
Phosphagenics
Pacgen Life Science Corporation